Dissertation · Open access
Development of nanosystems to overcome resistance in pancreatic cancer cells
Institutional Research Information System University of Turin (University of Turin)
In brief
“Development of nanosystems to overcome resistance in pancreatic cancer cells” is a dissertation by Valeria Bincoletto, published in Institutional Research Information System University of Turin (University of Turin). OpenAlex counts 0 citations as of 21 November 2026. It is open access: the full text is free to read at Institutional Research Information System University of Turin (University of Turin).
- Citations
- 0
- References
- 338
- Authors
- 1
Abstract
Nanomedicine represents a promising strategy to enhance the therapeutic potential of conventional drugs through the design of advanced drug delivery systems.Pancreatic cancer remains one of the most aggressive cancers, with a poor prognosis due to late diagnosis and resistance to chemotherapy.The aim of this work was the development of nanocarriers for the targeted and efficient delivery of gemcitabine (GEM) and its prodrugs (GEM-C12 and GEM-C18), with the goal of overcoming drug resistance and enhancing GEM therapeutic efficacy in pancreatic cancer.In the first part of the project, carbon nano-onions (CNOs) were covalently functionalized with hyaluronic acid (HA) to selectively target CD44-overexpressing pancreatic cancer cells.These nanocarriers exhibited excellent biocompatibility and selective uptake in CD44 + pancreatic cancer cell lines.CNOs were successfully loaded with GEM-C12 and GEM-C18, which showed strong cytotoxic activity even in GEM-resistant pancreatic cancer cells, with enhanced efficacy when delivered via the nanocarrier.In the second part, mixed micelles based on PEG-DSPE and HA-phospholipid conjugate (HA-DPPE) were developed to encapsulate GEM-C18.Mixed micelles demonstrated suitable physico-chemical characteristics, high encapsulation efficiency, and specific uptake by CD44 + cells.The presence of HA enabled active targeting without compromising micelle structure.The third part of the work included a literature review of current and emerging therapeutic strategies in pancreatic cancer, highlighting the limitations of standard chemotherapy regimens and exploring the potential of drug repurposing.In this context, the combination of GEM with disulfiram (DSF), a repurposed ALDH inhibitor, emerged as a promising approach to enhance cytotoxicity and overcome resistance mechanisms.Finally, two different liposomal formulations were developed to encapsulate either GEM or its prodrug GEM-C18.Both systems were characterized for their physico-chemical properties and in vitro release profiles.While the free drugs in combination with DSF demonstrated a significant increase in cytotoxicity in resistant pancreatic cancer cells, further studies are needed to confirm whether the liposomal formulations can replicate or enhance this synergistic effect.Nevertheless, their physico-chemical properties and controlled release profiles support their potential for combination therapy.Overall, this work presents complementary nanomedicine approaches to improve drug delivery and therapeutic outcomes in pancreatic cancer, offering promising strategies to overcome the limitations of conventional treatments.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bincoletto, V. (n.d.). Development of nanosystems to overcome resistance in pancreatic cancer cells. Institutional Research Information System University of Turin (University of Turin). https://hdl.handle.net/2318/2081572
MLA 9
Bincoletto, Valeria. “Development of nanosystems to overcome resistance in pancreatic cancer cells.” Institutional Research Information System University of Turin (University of Turin), n.d.. https://hdl.handle.net/2318/2081572.
Chicago
Bincoletto, Valeria. n.d.. “Development of nanosystems to overcome resistance in pancreatic cancer cells.” Institutional Research Information System University of Turin (University of Turin). https://hdl.handle.net/2318/2081572.
Harvard
Bincoletto, V. (n.d.) ‘Development of nanosystems to overcome resistance in pancreatic cancer cells’, Institutional Research Information System University of Turin (University of Turin). Available at: https://hdl.handle.net/2318/2081572.
IEEE
V. Bincoletto, “Development of nanosystems to overcome resistance in pancreatic cancer cells,” Institutional Research Information System University of Turin (University of Turin), n.d..
BibTeX
@phdthesis{bincolettodevelopment,
title = {{Development of nanosystems to overcome resistance in pancreatic cancer cells}},
author = {Bincoletto, Valeria},
url = {https://hdl.handle.net/2318/2081572}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- pancreatic cancer
- gemcitabine
- gemcitabine prodrug
- drug resistance
- nanocarriers
- carbon nano-onions
- hyaluronic acid
- CD44 targeting
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Bincoletto, V. (n.d.). Development of nanosystems to overcome resistance in pancreatic cancer cells. Institutional Research Information System University of Turin (University of Turin). https://hdl.handle.net/2318/2081572
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Institutional Research Information System University of Turin (University of Turin): sign in and open the PDF from this page.
Who wrote this paper?
Valeria Bincoletto.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.